Philippines President Orders Prices Of Five ‘Essential Drugs' Cut In Half
This article was originally published in PharmAsia News
Executive Summary
The Philippines president ordered a cap on the prices of five types of drugs deemed essential, with the effect of cutting the prices in half as of Aug. 15. The action had been recommended after drug makers failed to lower the prices of the five drugs on their own while agreeing to cut them on another 16 on the government's list. The industry also volunteered to cut prices of some drugs not on the list and said the order by President Gloria Macapagal Arroyo was not the best way to get essential drugs to The Philippines' poor. (Click here for moreYou may also be interested in...
Gene Therapy Approvals By US FDA Could Double In 2020
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Long Hot Summer For Novel Drug Reviews Forecast At US FDA
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports